| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 11 Jun 2024 | 11 Jun 2024 |
| Appointment of Interim CFO | ||
| Board Meeting | 16 May 2024 | 10 Apr 2024 |
| BIOCON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2024 ,inter alia, to consider and approve Audited standalone and consolidated results and to consider recommendation of dividend, if any, amongst other routine matters. The Board has approved the appointment of Mr. Atul Dhawan as an Additional Director (Non Executive and Independent) of the Company w.e.f. May 16, 2024. Outcome of Board Meeting held on May 16, 2024 Outcome of Board meeting and Audited Financials Results for the financial year ended 31.03.2024 The Board recommended a final dividend at the rate of 10% i.e. Re. 0.50 per equity share, subject to the shareholders approval. (As Per BSE Announcement dated on 16.05.2024) | ||
| Board Meeting | 8 Feb 2024 | 10 Jan 2024 |
| BIOCON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 inter alia to consider and approve Please find attached the Board Meeting Intimation for considering the Financial Results for Quarter ended December 31 2023. Outcome of Board Meeting (As Per BSE Announcement Dated on: 08/02/2024) | ||
| Board Meeting | 10 Nov 2023 | 9 Oct 2023 |
| BIOCON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve un-audited standalone and consolidated financial results for the quarter and half year ended September 30 2023 amongst other routine matters. Outcome of Board Meeting and Financial Results for the quarter and half-year ended September 30, 2023 Outcome of Board meeting held on November 10, 2023 (As Per BSE Announcement Dated on 10.11.2023) | ||
| Board Meeting | 10 Aug 2023 | 21 Jul 2023 |
| BIOCON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 inter alia to consider and approve the un-audited standalone and consolidated financial results for the quarter ended June 30 2023 BIOCON LIMITED has informed BSE about Board Meeting to be held on 10 Aug 2023 to consider financial statements for the period ended June 2023. Financial results. Outcome of Board Meeting Appointment of Director (As per BSE Announcement Dated on 10/08/2023) The appointment of Mr. Nicholas Robert Haggar as an Additional Director (category: Independent) on the Board of Biocon Limited is effective from September 01, 2023. (As Per BSE Announcement Dated on 01/09/2023) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
